Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|June 1, 1995
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growthP L Lollini, C De Giovanni, L Landuzzi, et al.
Human Pathology|April 1, 1996
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumorK Scotlandi, M Serra, M C Manara, et al.
British Journal of Cancer|November 1, 1993
Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cellsD Lauri, C De Giovanni, T Biondelli, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Cancer Research|September 1, 1996
Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cellsC De Giovanni, L Landuzzi, F Frabetti, et al.
Cancer Research|September 29, 1998
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic miceK Scotlandi, S Benini, P Nanni, et al.
British Journal of Cancer|November 1, 1996
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cellsP Nanni, C De Giovanni, L Landuzzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cellsS Benini, M C Manara, N Baldini, et al.
Pageof 11